Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Core Viewpoint - Shuttle Pharmaceuticals Holdings, Inc. has successfully closed a private placement, raising $4.25 million to support its operations and potential acquisitions [1][2]. Group 1: Financial Details - The company issued 1,180,877 shares of common stock at a purchase price of $3.60 per share, in accordance with Nasdaq rules [2]. - The gross proceeds from the offering amount to $4.25 million, which will be utilized for acquisitions, marketing, and general corporate purposes [1]. Group 2: Company Overview - Shuttle Pharmaceuticals is focused on enhancing outcomes for cancer patients undergoing radiation therapy by developing therapies that maximize the effectiveness of radiation while minimizing side effects [6]. - The company's mission includes increasing cancer cure rates, prolonging patient survival, and improving quality of life through the development of radiation sensitizers [6].